Please login to the form below

Not currently logged in
Email:
Password:

Acadia

This page shows the latest Acadia news and features for those working in and with pharma, biotech and healthcare.

Nuplazid backed by FDA panel as first-ever Parkinson's psychosis drug

Nuplazid backed by FDA panel as first-ever Parkinson's psychosis drug

Nuplazid backed by FDA panel as first-ever Parkinson's psychosis drug. Concludes Acadia Pharmaceuticals’ drug provides ‘ modest but meaningful’ benefits. ... Acadia Pharmaceuticals is celebrating an FDA panel verdict that could set its Nuplazid

Latest news

More from news
Approximately 2 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Damien McDevitt moves from GSK to Acadia Pharmaceuticals Damien McDevitt moves from GSK to Acadia Pharmaceuticals

    US biopharmaceutical company Acadia Pharmaceuticals has appointed Damien McDevitt (pictured) as senior vice president of corporate development. ... Meanwhile, Acadia’s SVP, technology development and operations Jim Nash will retire in January.

  • Juniper Pharmaceuticals adds to board of directors Juniper Pharmaceuticals adds to board of directors

    Dr Gray has over 20 years of biotechnology and biopharmaceutical experience and is the owner and president of Gray Strategic Advisors as well as serving on the boards of Acadia Pharmaceuticals,

  • Srdjan Stankovic joins Acadia Pharmaceuticals Srdjan Stankovic joins Acadia Pharmaceuticals

    Srdjan Stankovic joins Acadia Pharmaceuticals. He moves to the San Diego biopharma from Alkermes. ... Acadia is at the forefront in developing groundbreaking medicines to treat debilitating symptoms associated with these diseases.

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
FCB Halesway

A Eureka moment! A converted dairy in the Hampshire countryside back in 1993 saw the inception of Halesway as a...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics